Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial

Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:19:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T20:28:44.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor update with no substantive changes to the page content.
    Difference
    0.0%
    Check dated 2026-03-11T18:49:31.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new site revision (Revision: v3.4.2) was added and an older funding-status notice along with Revision: v3.4.1 were removed; these changes are administrative and do not affect the study details or content.
    Difference
    0.4%
    Check dated 2026-02-11T05:09:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A new notice about a lapse in government funding was added and the site version updated to v3.4.1; the previous version reference v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-04T04:38:01.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page adds a glossary toggle and updates metadata labels, including a new 'Last Update Submitted that Met QC Criteria' entry and a new 'Revision: v3.4.0' tag, with adjusted capitalization for 'No FEAR Act' data. These changes are UI/metadata improvements and do not alter core study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T01:59:57.000Z thumbnail image

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.